CN112675108A - Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof - Google Patents
Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof Download PDFInfo
- Publication number
- CN112675108A CN112675108A CN202011631734.1A CN202011631734A CN112675108A CN 112675108 A CN112675108 A CN 112675108A CN 202011631734 A CN202011631734 A CN 202011631734A CN 112675108 A CN112675108 A CN 112675108A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- extract
- eye cream
- moisturizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 58
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 35
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims abstract description 26
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 23
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 23
- 229940036350 bisabolol Drugs 0.000 claims abstract description 23
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940069521 aloe extract Drugs 0.000 claims abstract description 22
- 229940064064 purslane extract Drugs 0.000 claims abstract description 19
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 claims abstract description 18
- 229940093441 palmitoyl oligopeptide Drugs 0.000 claims abstract description 18
- 241000219357 Cactaceae Species 0.000 claims abstract description 11
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 25
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 24
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 18
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000002562 thickening agent Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 12
- 229960000458 allantoin Drugs 0.000 claims description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 11
- 229940049964 oleate Drugs 0.000 claims description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 11
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 11
- 230000037303 wrinkles Effects 0.000 claims description 11
- 240000007817 Olea europaea Species 0.000 claims description 10
- FSEJJKIPRNUIFL-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-octadecanoyloxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCCCCCCCC FSEJJKIPRNUIFL-UHFFFAOYSA-N 0.000 claims description 10
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 10
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 claims description 9
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 9
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 9
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 9
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 9
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 9
- 229940057910 shea butter Drugs 0.000 claims description 9
- 229940032094 squalane Drugs 0.000 claims description 9
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 9
- 240000001439 Opuntia Species 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 229920002307 Dextran Polymers 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- 229960001631 carbomer Drugs 0.000 claims description 7
- 229920002367 Polyisobutene Polymers 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 5
- 229940068977 polysorbate 20 Drugs 0.000 claims description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 229920001503 Glucan Polymers 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229940096857 opUNTia ficus-indica extract Drugs 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 1
- 230000007794 irritation Effects 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 4
- 208000026935 allergic disease Diseases 0.000 abstract description 4
- 230000007815 allergy Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 40
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 240000005729 Cylindropuntia imbricata Species 0.000 description 3
- 235000001427 Cylindropuntia imbricata Nutrition 0.000 description 3
- 235000001855 Portulaca oleracea Nutrition 0.000 description 3
- 241000219304 Portulacaceae Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 244000184734 Pyrus japonica Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- -1 cetyl alcohol ester Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000003560 epithelium corneal Anatomy 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BVHIKUCXNBQDEM-JSNMRZPZSA-N (3s,4r,5s)-5-(4-hydroxy-3-methoxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]-4-(hydroxymethyl)oxolan-3-ol Chemical compound C1=C(O)C(OC)=CC(C[C@]2(O)[C@@H]([C@H](OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 BVHIKUCXNBQDEM-JSNMRZPZSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710196022 Cuticle protein Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NYDZRKZVFLLTLO-UHFFFAOYSA-N Neoolivil Natural products C1=C(O)C(OC)=CC(C2C(C(CO)C(O2)C=2C=C(OC)C(O)=CC=2)CO)=C1 NYDZRKZVFLLTLO-UHFFFAOYSA-N 0.000 description 1
- BVHIKUCXNBQDEM-UHFFFAOYSA-N Olivil Natural products C1=C(O)C(OC)=CC(CC2(O)C(C(OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 BVHIKUCXNBQDEM-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 125000005610 enamide group Chemical group 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The application provides a moisturizing, relieving and anti-wrinkle eye cream and a preparation method thereof, and belongs to the field of daily cosmetics. The moisturizing, soothing and anti-wrinkle eye cream provided by the application comprises palmitoyl tripeptide-1, a twisted cactus extract, an aloe extract, a purslane extract, bisabolol, a ginger root extract and an auxiliary agent. By using the twisted cactus extract, the aloe extract, the purslane extract and the bisabolol in combination with the palmitoyl tripeptide-1 and the ginger root extract, the allergy and irritation symptoms caused by applying the palmitoyl tripeptide-1 to individual people and the irritation of the ginger root extract to the injured skin are relieved or even eliminated.
Description
Technical Field
The application relates to the field of daily cosmetics, in particular to moisturizing, relieving and wrinkle resisting eye cream and a preparation method thereof.
Background
Eyes are windows of soul, beautiful eyes are eagerly owned by every woman who likes beauty, but with the increasing responsibility of the women in the current society, the pressure is higher and higher, and the women who work overtime and stay up to night are also common, so that the women are easy to suffer from endocrine disturbance, the sleep quality is reduced, and the sleep is seriously insufficient, so that the eyes are dry, the skin is aged too fast, and especially the relatively delicate eye skin is aged quickly, so that the moisturizing, relaxing and anti-wrinkle eye cream can relieve the eye fatigue to a certain extent, and helps the beauty-lover people to have the eyes which are bright and vivid.
Content of application
The first aspect of the application discloses a moisturizing, soothing and anti-wrinkle eye cream, which comprises palmitoyl tripeptide-1, a twisted cactus extract, an aloe extract, a purslane extract, bisabolol, a ginger root extract and an auxiliary agent.
The palmitoyl tripeptide-1 can remove wrinkles of the skin and restore the elasticity, tenderness, whiteness and luster of the skin, and the palmitoyl tripeptide-1 is a special amino acid which is necessary for the skin, can promote the metabolism of the skin and stimulate the proliferation of cells, so the palmitoyl tripeptide-1 can remove the wrinkles, whiten the skin and make the skin glossy, but can generate symptoms of allergy and stimulation after being applied by very individual people, such as erythema, pimple, pruritus and the like on the skin. The ginger root extract has effects of keeping moisture and inhibiting odor, but has irritation when it is used externally, and has greater irritation to injured skin.
The prickly pear extract contains rich proteins, vitamins, carotene, calcium, magnesium, potassium and other mineral substances and amino acids, and the stem and leaf of the prickly pear extract contains polysaccharide, triterpenoid, malic acid, azululosic acid, resin, tartaric acid, quercetin and other components, so that the prickly pear extract can effectively help to delay the aging of the body and relieve the adverse reaction of skin stimulation to the outside. The aloe contains aloe polysaccharide, amino acids, metal salts, etc. which have the same components as natural moisturizing factors, has good moisturizing effect, and can provide a natural moisturizing system for skin. The purslane extracting solution has the comprehensive performance of preventing dry aging, increasing the comfort level of skin, removing free radicals, improving the comfortable feeling of skin and the like in winter; the bisabolol has anti-inflammatory and antibacterial activity.
In the first aspect of the application, due to the existence of the cactus extract, the aloe extract, the extract of the madaga and the bisabolol, the individual people can relieve or even eliminate the symptoms of allergy and irritation caused by the application of the palmitoyl tripeptide-1 and the irritation of the ginger root extract to the injured skin.
In the first aspect of the present application, the auxiliary agent may be one that is already present in the prior art or commonly used, as long as it does not affect the performance of the main components of the present application, such as palmitoyl tripeptide-1, twisted cactus extract, aloe extract, purslane extract, bisabolol, and ginger root extract.
In some embodiments of the foregoing first aspect, specifically defined are palmitoyl tripeptide-12-3 parts by weight, opuntia ficus-indica extract 2-3 parts by weight, aloe extract 1-3 parts by weight, purslane extract 1 part by weight, bisabolol 0.05-0.15 parts by weight, ginger root extract 0.05-0.15 parts by weight, and adjuvant 85-90 parts by weight.
The application discloses in the first aspect, moisturizing, relieving and wrinkle resisting eye cream with traditional Chinese medicines, and for the field of traditional Chinese medicines, the two most important aspects are components and proportions, the components are different, the effects are naturally different, but for many prescriptions, the proportions are different, and the effects may also be very different.
In some embodiments of the foregoing first aspect, the adjuvant comprises an emulsifier, a grease, a thickener, a humectant, and water.
During the action of the emulsifier, the dispersed phase is dispersed in the form of micro-droplets (micron-sized) in the continuous phase, and the emulsifier reduces the interfacial tension of each component in the mixed system, forms a firmer film on the surface of the micro-droplets or forms an electric double layer on the surface of the micro-droplets due to the charge given by the emulsifier, prevents the micro-droplets from aggregating with each other, maintains uniform emulsion and improves the stability of the system.
The oil and fat has effects of protecting, moistening and softening skin. The humectant can improve the moisturizing capability of the eye cream, so that the eye cream can lock the moisture of the skin, and the skin of the eye cream is relaxed and relaxed after the eye cream is used. The thickening agent can increase the viscosity of the eye cream, so that the eye cream can reach a specified physical form and can be kept in a uniform and stable state for a long time, and when the thickening agent is selected, some viscosity regulators with an emulsifying effect can be selected, so that the stability of a system is improved. The water can be matched with oil, humectant, etc. to play the roles of keeping moisture and adjusting viscosity.
In some embodiments of the foregoing first aspect, the emulsifier comprises 2-5 parts by weight cetearyl olive oleate and 1-2 parts by weight pentaerythritol distearate.
Cetearyl olive oleate is also known as: the olive oil cetyl alcohol ester, the olive oil sorbitol ester and the sorbitan olive oleate have high moisture retention and film forming properties besides being used as an emulsifying agent, and effectively and slowly release active ingredients so as to be better absorbed by the skin. The pentaerythritol distearate can be used as an emulsifier and a lubricant, so that the eye cream has smoother hand feeling.
In some embodiments of the foregoing first aspect, the oil or fat comprises cetearyl alcohol 0.3 to 1 part by weight, caprylic/capric triglyceride 3 to 8 parts by weight, squalane 2 to 5 parts by weight, shea butter 1 to 3 parts by weight, and isodecyl neopentanoate 1 to 3 parts by weight.
The oil-water separating agent adopts various oils to be matched with each other, can integrate the advantages of various oils, and can better exert the functions of protection, wetting and softening.
In some embodiments of the foregoing first aspect, the moisturizer further comprises 2 to 6 parts by weight of 1, 3-butanediol, 4 to 6 parts by weight of glycerin, 0.1 to 0.3 parts by weight of sodium hyaluronate, 1 to 4 parts by weight of dextran, 11 parts by weight of bioglycan-m and 0.2 parts by weight of allantoin.
Sodium hyaluronate is an acidic mucopolysaccharide, naturally exists in corneal epithelium, can absorb 1000 times of water by weight of the corneal epithelium so as to achieve the purposes of keeping skin water, preventing water from losing through epidermis, and repairing a barrier when the skin is damaged, so that the skin does not feel dry after being used, the skin luster is increased, the sodium hyaluronate can improve the skin nutrition metabolism, make the skin soft and smooth, remove wrinkles, increase elasticity and prevent aging, and is a good transdermal absorption promoter while keeping moisture. The glucan has film forming property, can help skin to keep moisture, remarkably reduce skin wrinkles and improve skin elasticity.
The biogum carbohydrate gum-1 contains a plurality of sulfate groups in molecules, has polyanion compound property and can stabilize an emulsion system; has strong hydration ability, can absorb water even in a low humidity environment, and has good moisture retention and wettability.
The allantoin is an amphoteric compound, can combine with various substances to form a double salt, has the functions of shading light, sterilizing, preventing corrosion, relieving pain and resisting oxidation, promotes tissue growth and cell metabolism by the allantoin, softens cuticle protein, can keep moisture of skin, moistens and softens the skin, and can protect the tissue, make the skin soft and elastic by adding the allantoin into eye cream, and has the functions of hydrophile, water absorption, moisture diffusion prevention and the like, so the skin has beautiful luster.
In some embodiments of the foregoing first aspect, the thickener further comprises 0.2 to 0.6 parts by weight of thickener a and 0.1 to 0.6 parts by weight of carbomer, wherein thickener a is one or a mixture of several of acrylamide/ammonium acrylate copolymer, polyisobutylene, and polysorbate-20.
The stability of the product can be effectively improved by using various thickening agents.
In some embodiments of the foregoing first aspect, further comprising 0.1 to 1 part by weight of tocopheryl acetate, 0.08 part by weight of perfume, and 0.6 part by weight of preservative.
The tocopherol acetate belongs to vitamin E derivatives, has strong reducibility, and has the functions of resisting oxidation and preventing aging in the metabolism process of a human body.
The preservative can prolong the shelf life of the eye cream; the essence can make the eye cream emit fragrance, and the antiseptic and the essence can be selected according to the needs on the basis of the prior art.
A second aspect of the present application provides a method for preparing a moisturizing, soothing and anti-wrinkle eye cream, comprising:
mixing palmitoyl tripeptide-1, the prickly pear extract, the aloe extract, the purslane extract, bisabolol, the ginger root extract and an auxiliary agent, and homogenizing at 50-55 ℃ for 25-30min, wherein the rotation speed of a homogenizer in the homogenizing step is 11000-13000r/min, so as to obtain the moisturizing, soothing and anti-wrinkle eye cream.
In the preparation method of the moisturizing, relieving and anti-wrinkle eye cream provided by the second aspect of the application, a proper formula is selected, and the shower gel is matched with technological parameters of the step, so that the effect of the shower gel is guaranteed, and the stability of the product is improved.
In some embodiments of the foregoing second aspect, there is further defined a method of making a moisturizing, soothing, and anti-wrinkle eye cream comprising:
mixing 12-3 parts by weight of palmitoyl tripeptide, 2-3 parts by weight of twisted cactus extract, 1-3 parts by weight of aloe extract, 1 part by weight of purslane extract, 0.05-0.15 part by weight of bisabolol, 0.05-0.15 part by weight of ginger root extract, 2-6 parts by weight of 1, 3-butanediol, 4-6 parts by weight of glycerol, 0.1-0.3 part by weight of sodium hyaluronate, 1-4 parts by weight of glucan, 11 parts by weight of bioglycan-11 and 0.2 part by weight of allantoin to obtain a mixture A;
mixing 2-5 parts by weight of cetearyl olive oleate, 1-2 parts by weight of pentaerythritol distearate, 0.3-1 part by weight of cetearyl alcohol, 3-8 parts by weight of caprylic/capric triglyceride, 2-5 parts by weight of squalane, 1-3 parts by weight of shea butter and 1-3 parts by weight of isodecyl neopentanoate to obtain a mixture B;
mixing the mixture A with the mixture B to obtain a mixture C;
and mixing the mixture C, a thickening agent and a proper amount of water, and homogenizing to obtain the moisturizing, soothing and anti-wrinkle eye cream.
Compared with the prior art, the moisturizing, soothing and anti-wrinkle eye cream provided by the application has the advantages that the prickly pear extract, the aloe extract, the purslane extract, the bisabolol, the palmitoyl tripeptide-1 and the ginger root extract are used in a matching manner, so that the allergy and irritation symptoms generated after the palmitoyl tripeptide-1 is applied to individual people and the irritation of the ginger root extract to damaged skin are relieved or even eliminated.
Detailed Description
Embodiments of the present application will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present application and should not be construed as limiting the scope of the present application. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The features and properties of the present application are described in further detail below with reference to examples.
Example 1
The embodiment provides moisturizing, soothing and anti-wrinkle eye cream which comprises 12-3 parts by weight of palmitoyl tripeptide, 2-3 parts by weight of opuntia ficus-indica extract, 1-3 parts by weight of aloe extract, 1 part by weight of purslane extract, 0.05-0.15 part by weight of bisabolol, 0.05-0.15 part by weight of ginger root extract and 85-90 parts by weight of auxiliary agent.
Example 2
The embodiment provides a preparation method of a moisturizing, soothing and anti-wrinkle eye cream, which comprises mixing palmitoyl tripeptide-12-3 parts, cactus extract 2-3 parts, aloe extract 1-3 parts, purslane extract 1 part, bisabolol 0.05-0.15 part, ginger root extract 0.05-0.15 part, 1, 3-butanediol 2-6 parts, glycerol 4-6 parts, sodium hyaluronate 0.1-0.3 part, dextran 1-4 parts, biosugar gum-11 parts and allantoin 0.2 part by weight to obtain a mixture A;
mixing 2-5 parts by weight of cetearyl olive oleate, 1-2 parts by weight of pentaerythritol distearate, 0.3-1 part by weight of cetearyl alcohol, 3-8 parts by weight of caprylic/capric triglyceride, 2-5 parts by weight of squalane, 1-3 parts by weight of shea butter and 1-3 parts by weight of isodecyl neopentanoate to obtain a mixture B;
mixing the mixture A with the mixture B to obtain a mixture C;
mixing the mixture C, 0.2-0.6 part by weight of thickening agent A, 0.1-0.6 part by weight of carbomer and a proper amount of water, and homogenizing at 50-55 ℃ for 25-30min, wherein the rotating speed of a homogenizer in the homogenizing step is 11000-13000r/min to obtain the moisturizing, soothing and anti-wrinkle eye cream;
wherein the thickener A is one or more of acrylamide/ammonium acrylate copolymer, polyisobutylene and polysorbate-20.
Example 3
This example provides the moisturizing soothing anti-wrinkle eye cream of example 2,
comprises 12 to 3 weight portions of palmitoyl tripeptide, 2 to 3 weight portions of cholla japonica extract, 1 to 3 weight portions of aloe extract, 1 weight portion of purslane extract, 0.05 to 0.15 weight portion of bisabolol, 0.05 to 0.15 weight portion of ginger root extract, 2 to 6 weight portions of 1, 3-butanediol, 4 to 6 weight portions of glycerol, 0.1 to 0.3 weight portion of sodium hyaluronate, 1 to 4 weight portions of dextran, 11 weight portions of bioglycan gum, 0.2 weight portion of allantoin, 2 to 5 weight portions of cetearyl olivil oleate, 1 to 2 weight portions of pentaerythritol distearate, 0.3 to 1 weight portion of cetearyl alcohol, 3 to 8 weight portions of caprylic/capric triglyceride, 2 to 5 weight portions of squalane, 1 to 3 weight portions of shea butter, 1-3 parts of isodecyl neopentanoate, 0.2-0.6 part of thickener A, 0.1-0.6 part of carbomer and a proper amount of water;
wherein the thickener A is one or more of acrylamide/ammonium acrylate copolymer, polyisobutylene and polysorbate-20.
Example 4
The embodiment further defines the moisturizing, relieving and anti-wrinkle eye cream on the basis of the embodiment 3, the composition comprises 12 parts by weight of palmitoyl tripeptide, 3 parts by weight of cholla japonica extract, 3 parts by weight of aloe extract, 1 part by weight of purslane extract, 0.15 part by weight of bisabolol, 0.05 part by weight of ginger root extract, 2 parts by weight of 1, 3-butanediol, 4 parts by weight of glycerol, 0.3 part by weight of sodium hyaluronate, 4 parts by weight of dextran, 11 parts by weight of bioglycan gum, 0.2 part by weight of allantoin, 5 parts by weight of cetearyl olive oleate, 1 part by weight of pentaerythritol distearate, 0.3 part by weight of cetearyl alcohol, 3 parts by weight of caprylic/capric triglyceride, 5 parts by weight of squalane, 3 parts by weight of shea butter, 3 parts by weight of isodecyl neopentanoate, 0.2 part by weight of enamide/ammonium acrylate copolymer, 0.6 part by weight of carbomer and 88 parts by weight of water.
Example 5
The embodiment further defines the moisturizing, relieving and anti-wrinkle eye cream on the basis of the embodiment 3, the composition comprises 13 parts by weight of palmitoyl tripeptide, 2 parts by weight of prickly pear extract, 1 part by weight of aloe extract, 1 part by weight of purslane extract, 0.05 part by weight of bisabolol, 0.15 part by weight of ginger root extract, 6 parts by weight of 1, 3-butanediol, 6 parts by weight of glycerol, 0.1 part by weight of sodium hyaluronate, 1 part by weight of dextran, 11 parts by weight of biogan gum, 0.2 part by weight of allantoin, 2 parts by weight of cetearyl olive oleate, 2 parts by weight of pentaerythritol distearate, 1 part by weight of cetearyl alcohol, 8 parts by weight of caprylic/capric triglyceride, 2 parts by weight of squalane, 1 part by weight of shea butter, 1 part by weight of isodecyl neopentanoate, 0.6 part by weight of a mixture of polyisobutylene and polysorbate-20, 0.1 part by weight of carbomer and 90 parts by weight of water.
Example 6
The embodiment further defines the moisturizing, relieving and anti-wrinkle eye cream on the basis of the embodiment 3, the composition comprises 12.5 parts by weight of palmitoyl tripeptide, 2.5 parts by weight of cholla taeda extract, 2 parts by weight of aloe extract, 1 part by weight of purslane extract, 0.1 part by weight of bisabolol, 0.1 part by weight of ginger root extract, 4 parts by weight of 1, 3-butanediol, 5 parts by weight of glycerol, 0.2 part by weight of sodium hyaluronate, 3 parts by weight of dextran, 11 parts by weight of biogan gum, 0.2 part by weight of allantoin, 3 parts by weight of cetearyl olive oleate, 1.5 parts by weight of pentaerythritol distearate, 0.7 part by weight of cetearyl alcohol, 6 parts by weight of caprylic/capric triglyceride, 3 parts by weight of squalane, 2 parts by weight of shea butter, 2 parts by weight of isodecyl pivalate, 0.4 part by weight of a mixture of enamine/ammonium acrylate copolymer and polyisobutylene, 0.4 part by weight of carbomer and 85 parts by weight of water.
Experimental example 1
The difference from example 6 is that palmitoyl tripeptide-1 is not contained therein.
Experimental example 2
The difference from example 6 is that it does not contain ginger root extract.
Experimental example 3
The difference from example 6 is that it does not contain cactus extract and aloe extract.
Experimental example 4
The difference from example 6 is that the purslane extract and bisabolol are not contained therein.
Recording objects that partially use the product:
some king, female, age 35, no damage to eye skin: the eye cream in the experimental example 2 is used for three months, discomfort symptoms do not exist, eye skin is moist and not tight, but the wrinkle removing effect is poor; after the eye cream is stopped for one month, the eye cream in the experimental example 3 is used for two weeks, the moistening degree is slightly better than that in the experimental example 1, but the eye cream feels slightly irritated, and the eye skin feels stabbing pain and is stopped; after the eye cream is stopped for one month, the eye cream in the experimental example 4 is used for two weeks, the moistening degree is slightly better than that in the experimental example 1, but the eye cream feels slightly irritated, and the eye skin feels stabbing pain and is stopped; after the eye cream in the example 6 is used for six months after being stopped for one month, the eye cream has no stinging feeling, the moisture degree is superior to that in the experimental examples 3 and 4, eye wrinkles become obviously shallow, and the palmitoyl tripeptide-1 has the wrinkle removing effect, and the stimulation of the palmitoyl tripeptide-1 to skin can be eliminated by using the twisted cactus extract, the aloe extract, the purslane extracting solution, the bisabolol and the palmitoyl tripeptide-1 in a matching way.
Zhangqi, female, age 27, ocular skin lesions: after one month, the eye cream in the example 3 is used for one week, the moistening degree is slightly better than that of the example 1, but the eye skin feels stabbing and painful and stops taking; after the eye cream is stopped for one week, the eye cream in the experimental example 4 is used, the moistening degree is slightly better than that in the experimental example 1, but the eye skin feels stabbing pain and the eye cream is stopped; after the eye cream in the embodiment 6 is used for six months after being stopped for one month, the eye cream does not have a tingling feeling, the moistening degree is superior to that in the experiment examples 3 and 4, eye wrinkles are obviously lightened, the ginger root extract can increase the moistening degree of the eye cream, and the prickly pear extract, the aloe extract, the purslane extracting solution, the bisabolol and the ginger root extract are matched for use, so that the irritation of the ginger root extract to the damaged skin can be eliminated.
The embodiments described above are some, but not all embodiments of the present application. The detailed description of the embodiments of the present application is not intended to limit the scope of the claimed application, but is merely representative of selected embodiments of the application. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
Claims (10)
1. The eye cream is characterized by comprising palmitoyl tripeptide-1, a twisted cactus extract, an aloe extract, a purslane extract, bisabolol, a ginger root extract and an auxiliary agent.
2. The moisturizing, soothing and anti-wrinkle eye cream according to claim 1, comprising palmitoyl tripeptide-12-3 parts by weight, opuntia contorta extract 2-3 parts by weight, aloe extract 1-3 parts by weight, purslane extract 1 part by weight, bisabolol 0.05-0.15 part by weight, ginger root extract 0.05-0.15 part by weight, and auxiliary agent 85-90 parts by weight.
3. The moisturizing, soothing and anti-wrinkle eye cream as claimed in claim 1, wherein the auxiliary agent comprises an emulsifier, a grease, a thickener, a humectant and water.
4. The moisturizing, soothing and anti-wrinkle eye cream as claimed in claim 3, wherein the emulsifier comprises 2-5 parts by weight of cetearyl olive oleate and 1-2 parts by weight of pentaerythritol distearate.
5. The moisturizing, soothing and anti-wrinkle eye cream as claimed in claim 3, wherein the oil comprises cetearyl alcohol 0.3-1 parts by weight, caprylic/capric triglyceride 3-8 parts by weight, squalane 2-5 parts by weight, shea butter 1-3 parts by weight, and isodecyl neopentanoate 1-3 parts by weight.
6. The moisturizing, soothing and wrinkle-resistant eye cream as claimed in claim 3, wherein the moisturizer further comprises 2-6 parts by weight of 1,3 butylene glycol, 4-6 parts by weight of glycerin, 0.1-0.3 part by weight of sodium hyaluronate, 1-4 parts by weight of dextran, 11 parts by weight of bioglycan and 0.2 part by weight of allantoin.
7. The moisturizing, soothing and wrinkle-resisting eye cream according to claim 3, wherein the thickener further comprises 0.2-0.6 parts by weight of thickener A and 0.1-0.6 parts by weight of carbomer, wherein the thickener A is one or a mixture of more of acrylamide/ammonium acrylate copolymer, polyisobutylene and polysorbate-20.
8. The moisturizing, soothing and anti-wrinkle eye cream according to claim 3, further comprising 0.1-1 parts by weight of tocopherol acetate, 0.08 parts by weight of essence, and 0.6 parts by weight of preservative.
9. A method for preparing the moisturizing, soothing and anti-wrinkle eye cream as claimed in claim 1, wherein palmitoyl tripeptide-1, the opuntia ficus-indica extract, the aloe extract, the purslane extract, the bisabolol, the ginger root extract and an auxiliary agent are mixed and homogenized at 50-55 ℃ for 25-30min, and the rotation speed of a homogenizer in the homogenizing step is 11000-.
10. The method for preparing the moisturizing, soothing and wrinkle-resisting eye cream according to claim 9,
mixing 12-3 parts by weight of palmitoyl tripeptide, 2-3 parts by weight of twisted cactus extract, 1-3 parts by weight of aloe extract, 1 part by weight of purslane extract, 0.05-0.15 part by weight of bisabolol, 0.05-0.15 part by weight of ginger root extract, 2-6 parts by weight of 1, 3-butanediol, 4-6 parts by weight of glycerol, 0.1-0.3 part by weight of sodium hyaluronate, 1-4 parts by weight of glucan, 11 parts by weight of bioglycan-11 and 0.2 part by weight of allantoin to obtain a mixture A;
mixing 2-5 parts by weight of cetearyl olive oleate, 1-2 parts by weight of pentaerythritol distearate, 0.3-1 part by weight of cetearyl alcohol, 3-8 parts by weight of caprylic/capric triglyceride, 2-5 parts by weight of squalane, 1-3 parts by weight of shea butter and 1-3 parts by weight of isodecyl neopentanoate to obtain a mixture B;
mixing the mixture A with the mixture B to obtain a mixture C;
and mixing the mixture C, a thickening agent and a proper amount of water, and homogenizing to obtain the moisturizing, soothing and anti-wrinkle eye cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011631734.1A CN112675108A (en) | 2020-12-31 | 2020-12-31 | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011631734.1A CN112675108A (en) | 2020-12-31 | 2020-12-31 | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112675108A true CN112675108A (en) | 2021-04-20 |
Family
ID=75456002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011631734.1A Pending CN112675108A (en) | 2020-12-31 | 2020-12-31 | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112675108A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006326A (en) * | 2022-06-21 | 2022-09-06 | 杭州孔凤春化妆品股份有限公司 | Purslane soothing mask and preparation method thereof |
| CN115120517A (en) * | 2022-08-22 | 2022-09-30 | 杨明振 | Preparation for removing eyewrinkles and under-eye puffiness and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100083448A (en) * | 2009-01-14 | 2010-07-22 | 한상훈 | Manufacturing method for beauty product of eye cream using caviar extracton |
| CN110302113A (en) * | 2019-08-06 | 2019-10-08 | 广州珈纳生物科技有限公司 | One kind is crease-resistant to remove black eye eye cream |
-
2020
- 2020-12-31 CN CN202011631734.1A patent/CN112675108A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100083448A (en) * | 2009-01-14 | 2010-07-22 | 한상훈 | Manufacturing method for beauty product of eye cream using caviar extracton |
| CN110302113A (en) * | 2019-08-06 | 2019-10-08 | 广州珈纳生物科技有限公司 | One kind is crease-resistant to remove black eye eye cream |
Non-Patent Citations (2)
| Title |
|---|
| 丁姣等: "生物活性美容多肽的研究进展", 《广东化工》 * |
| 国产非特殊用途化妆品备案服务平台: ""碳立方富勒臻至修护眼霜"", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=201807191034126KV16&NID=201807191034126KV16》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006326A (en) * | 2022-06-21 | 2022-09-06 | 杭州孔凤春化妆品股份有限公司 | Purslane soothing mask and preparation method thereof |
| CN115006326B (en) * | 2022-06-21 | 2024-04-12 | 杭州孔凤春化妆品股份有限公司 | Purslane soothing mask and preparation method thereof |
| CN115120517A (en) * | 2022-08-22 | 2022-09-30 | 杨明振 | Preparation for removing eyewrinkles and under-eye puffiness and preparation method and application thereof |
| CN115120517B (en) * | 2022-08-22 | 2024-06-25 | 杨明振 | Preparation for removing eye wrinkles and eye bags, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111000748A (en) | Polypeptide repairing cream and preparation method thereof | |
| KR102042960B1 (en) | Skin essence for skin moisturization and skin tone improvement | |
| US11090205B2 (en) | Methods and compositions for treatment of skin conditions | |
| CN105106660B (en) | A kind of kibe ointment and preparation method thereof of the easypro trace of skin care | |
| US10993922B2 (en) | Topical skin care compositions | |
| CN111053728A (en) | Composition for regulating water-oil balance of skin and cosmetic thereof | |
| KR20160131387A (en) | Composition for skin care | |
| CN112675108A (en) | Moisturizing, relieving and anti-wrinkle eye cream and preparation method thereof | |
| CN113768809A (en) | Composition with mild exfoliating effect and preparation method and application thereof | |
| CN112691070A (en) | Anti-aging composition, eye cream and preparation method thereof | |
| CN111973501A (en) | Ceramide activation milk and preparation method thereof | |
| RU2589279C1 (en) | Cosmetic composition for face and body skin care | |
| CN104188859B (en) | A kind of crease-resistant skin care emulsion containing natural component extract and preparation method thereof | |
| CN112315866A (en) | Black plant extract and application thereof | |
| CN111840140A (en) | Preparation method of vitamin E eye cream | |
| US20060134046A1 (en) | Skin nourishing and moisturizing cream | |
| CN104013561B (en) | One is full of moistens lock water temperature and nourishing type shampoo paste and preparation method thereof | |
| CN115337243A (en) | Blackhead removing composition and cosmetic | |
| KR20230046131A (en) | Cosmetic composition containing vitamins | |
| JPH01193205A (en) | Cosmetics composition | |
| CN105267122B (en) | A kind of natural moisture preserving pore refining gel and preparation method thereof | |
| CN111939113A (en) | Multi-effect eye muscle activating base solution and preparation method thereof | |
| RU2780260C1 (en) | Cosmetic for skin | |
| CN114099551B (en) | Asthenopia-relieving and eye-moistening composition | |
| CN108403553A (en) | Skin care compositions and methods after a kind of depilation of iris and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210420 |